Kennedy’s commitment to walk away from the potential windfall is a major reversal for the nominee, who in his ethics plan ...

President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...

Job openings (Dec.) Factory orders (Dec.) Alphabet Inc (NASDAQ:GOOGL) (Q3) EPS for gain of $2.12, compared to $1.64 in the prior-year quarter. Toyota Motor Corporation (NYSE:TM) (Q3) EPS of $4.36, ...

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that ...

Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...

Robert F. Kennedy Jr., Trump's pick to head the Department of Health and Human Services, faces scrutiny for fees he may earn ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

Merck on Friday said the recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use covers the 21-valent conjugate vaccine for immunization for the prevention ...

Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

After parting ways with BeiGene in 2023, Novartis effectively bowed out of the PD-1 race. | The rising class of bisepcifics ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...